Top Markets
#1 DogBull DogBull +53.26%
#2 OriginTrail OriginTrail +16.86%
#3 龙虾 (Lobster) 龙虾 (Lobster) +10.64%
#4 Siren Siren +10.53%
#5 Verus Coin Verus Coin +8.62%
#6 COTI COTI +7.40%
#7 Tutorial Tutorial +7.07%
#8 Stargate Finance Stargate Finance +7.05%
#9 PulseChain PulseChain +6.89%
#10 Yield Basis Yield Basis +6.63%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rang in Aktien #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Aktienkurs
$0.3479
Zuletzt synchronisiert: 2024-08-21
Marktkapitalisierung
$94.92M
Veränderung (1 Tag)
0.64%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Asensus Surgical, Inc. (ASXC)

Kategorie

Healthcare
Umsatz von Asensus Surgical, Inc. (ASXC)
Umsatz im Jun 2024 TTM: $9.85M
Laut den aktuellen Finanzberichten von Asensus Surgical, Inc. beträgt der derzeitige Umsatz des Unternehmens (TTM) $9.85M. Im Jahr 2022 erzielte das Unternehmen einen Umsatz von $7.09M ein Rückgang im Vergleich zu dem Umsatz im Jahr 2021, der $8.23M betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Asensus Surgical, Inc. von 2000 bis 2026
Umsatz am Ende jedes Jahres
Jahr Umsatz ändert
2026 (TTM) $9.85M 14.84%
2023 $8.58M 21.02%
2022 $7.09M -13.91%
2021 $8.23M 159.28%
2020 $3.18M -62.78%
2019 $8.53M -64.60%
2018 $24.10M 238.94%
2017 $7.11M 368.14%
2016 $1.52M 0.00%
2015 0.00 -100.00%
2014 $401.00K -71.98%
2013 $1.43M -32.34%
2012 $2.12M 0.00%
2011 0.00 -100.00%
2010 $-29.00 0.00%
2009 0.00 0.00%
2008 0.00 -100.00%
2007 $-135.00K 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $231.00K -98.04%
2002 $11.77M -42.34%
2001 $20.42M -21.40%
2000 $25.97M 0.00%
Umsatz vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Umsatz Umsatzunterschied Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 472,844.16%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 262,204.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 360,143.65%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 213,057.36%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE